The estimated Net Worth of Rob Cutler is at least $79.1 Thousand dollars as of 4 May 2023. Rob Cutler owns over 1,174 units of Telesis Bio Inc stock worth over $43,296 and over the last 12 years Rob sold TBIO stock worth over $35,779.
Rob has made over 3 trades of the Telesis Bio Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Rob sold 1,174 units of TBIO stock worth $3,322 on 4 May 2023.
The largest trade Rob's ever made was selling 20,252 units of Telesis Bio Inc stock on 6 April 2015 worth over $15,797. On average, Rob trades about 2,369 units every 307 days since 2013. As of 4 May 2023 Rob still owns at least 25,468 units of Telesis Bio Inc stock.
You can see the complete history of Rob Cutler stock trades at the bottom of the page.
Rob's mailing address filed with the SEC is C/O TELESIS BIO INC., 10431 WATERIDGE CIRCLE, SUITE 150, SAN DIEGO, CA, 92121.
Over the last 6 years, insiders at Telesis Bio Inc have traded over $269,224,467 worth of Telesis Bio Inc stock and bought 73,047,057 units worth $2,753,701,666 . The most active insiders traders include Sanofi, Plc Gsk, and Human Genetic Therapies, In.... On average, Telesis Bio Inc executives and independent directors trade stock every 88 days with the average trade being worth of $7,100,681. The most recent stock trade was executed by Todd Robert Nelson on 4 May 2023, trading 2,575 units of TBIO stock currently worth $7,287.
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Telesis Bio Inc executives and other stock owners filed with the SEC include: